Single-session percutaneous sclerotherapy in symptomatic simple renal cysts: long-term results. 2009

B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
Department of Radiology, A.Y. Ankara Oncology Training and Research Hospital, Ankara, Turkey. bilginaribas@hotmail.com

OBJECTIVE To evaluate the efficacy of single-session percutaneous sclerotherapy with needle aspiration or catheter drainage, under ultrasound (US) or computed tomography (CT) guidance, based on cyst size and depth in 22 symptomatic simple renal cysts. METHODS Sclerotherapy with 95% alcohol for 20 min was performed in 22 symptomatic simple renal cysts in 15 patients. The method (aspiration or drainage) was chosen according to cyst size and depth: catheter drainage was done for larger (>6 cm) and shallow (<7.5 cm) cysts (N=12) and needle aspiration was done for smaller (<6 cm) or deeper (>7.5 cm) cysts (N=10). The median follow-up period was 6.0 months (range 1-62). RESULTS Volume reduction of cysts (mean and median, respectively) was 94.1% and 97.0%. Average cyst volume reduction (mean and median, respectively) was 94.7% and 96.0% with US-guided methods and 93.3% and 99.0% with CT-guided methods (P=0.382). Median volume loss was 97.5% with needle aspiration and 96.5% with catheter drainage (P=0.839). No correlation between the groups and volume reduction was found. All procedures were successful. No major complications or recurrences were noted. CONCLUSIONS Single-session percutaneous alcohol sclerotherapy with needle aspiration or catheter drainage, under US or CT guidance, is an effective and safe method for treating symptomatic simple renal cysts. CT-guided needle aspiration may be more suitable for treating deeper and/or smaller (<6 cm) cysts, while US-guided catheter drainage may be preferable in cases of shallow and/or larger (>6 cm) cysts.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012597 Sclerosing Solutions Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. Injections, Sclerosing,Sclerosant,Sclerosing Agent,Sclerosing Agents,Sclerosing Injection,Sclerosing Solution,Sclerosants,Sclerosing Drugs,Sclerosing Injections,Agent, Sclerosing,Agents, Sclerosing,Drugs, Sclerosing,Injection, Sclerosing,Solution, Sclerosing,Solutions, Sclerosing

Related Publications

B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
May 2005, European journal of radiology,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
February 2005, Pediatric radiology,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
November 1999, Acta radiologica (Stockholm, Sweden : 1987),
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
January 2001, Urology,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
December 2012, Journal of vascular and interventional radiology : JVIR,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
January 2001, International urology and nephrology,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
November 1997, Acta radiologica (Stockholm, Sweden : 1987),
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
June 1995, Journal of endourology,
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
January 2016, Diagnostic and interventional radiology (Ankara, Turkey),
B K Aribas, and G Dingil, and K Doğan, and G Kaya, and D N Unlü, and K Yilmaz, and G Sahin, and Z Simsek, and P Demir
December 2005, BJU international,
Copied contents to your clipboard!